Rheumatoid Arthritis
A new clinical trial for people with Rheumatoid Arthritis.
Study site: Encore Medical Research
- Rheumatoid arthritis
Recruiting
Male/Female
18+ years of age
Compensation Provided
- About the Study
- The aim of this trial is to investigate whether a potential new treatment can improve symptoms in people with Rheumatoid Arthritis who have not responded to standard drugs. This medicine has not yet been approved for the treatment of Rheumatoid Arthr itis and is being investigated in clinical trials.
- What does the study involve?
- If this trial is a good fit and you would like to take part, you would be expected to participate in the study for about 10 months and attend 19 clinic visits (every 2 weeks during treatment, then every 4 weeks after the last dose).
- Who can participate?
- To be eligible you must have been diagnosed with Rheumatoid Arthritis, and be receiving treatment with at least 1 but not more than 2 of the following drugs: methotrexate, leflunomide, sulfasalazine, hydroxychloroquine or chloroquine.
- Is compensation provided?
- Yes: $1+ for taking part.
Where is the study taking place?
Boynton Beach
Study details
Full record on ClinicalTrials.gov (NCT06041269)Study details are from ClinicalTrials.gov. The rest of this page is written by the study site for patients and may summarize or reword the registry record, which is the official text. A study listed on ClinicalTrials.gov has not necessarily been reviewed or approved by the U.S. government.
One moment…
About Encore Medical Research
Encore Medical Research has been serving the South Florida Community since 2017 focusing on phases II through IV clinical trials. Our goal is to provide the highest standard of care to our patients while delivering unmatched performance in our research operations.